Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;29(1):109-18.
doi: 10.1093/ndt/gft349. Epub 2013 Oct 22.

Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy

Affiliations

Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy

Koki Mise et al. Nephrol Dial Transplant. 2014 Jan.

Abstract

Background: A new classification of diabetic nephropathy was reported by Tervaert et al., but the association between pathological findings and the clinical outcomes remains unclear.

Methods: Among 310 patients with diabetes mellitus who underwent renal biopsy from March 1985 to January 2010 and were confirmed to have diabetic nephropathy according to the Tervaert's classification, 205 patients were enrolled in this study. Cox proportional hazard regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for death-censored renal death. Each regression analysis employed two levels of multivariate adjustment.

Results: After adjustment for age, gender, estimated glomerular filtration rate, type of diabetes, urinary protein excretion, systolic blood pressure, body mass index, HbA1c, diabetic retinopathy and red blood cells in urinary sediment at the time of renal biopsy, compared with glomerular class IIA, the HRs for death-censored renal death of glomerular classes I, IIB, III and IV were 0.21 (95% CI: 0.04-1.25), 2.12 (0.89-5.04), 4.23 (1.80-9.90), and 3.27 (1.32-8.10), respectively. Also, compared with an interstitial fibrosis and tubular atrophy score 1 group, HRs for score 0 group, score 2 group and score 3 group were 0.08 (0.01-0.57), 2.17 (0.96-4.91), 4.78 (1.96-11.68), respectively.

Conclusions: The progression of glomerular, tubulointerstitial and vascular lesions was associated with higher HRs for renal death. These results suggest the clinical utility of Tervaert's pathological classification.

Keywords: diabetic nephropathy; pathological classification; renal prognosis.

PubMed Disclaimer

Figures

FIGURE 1:
FIGURE 1:
Flowchart of study participants. eGFR: estimated glomerular filtration rate.
FIGURE 2:
FIGURE 2:
(a) Renal survival rates in glomerular classes. The 5-year renal survival rate in our study was estimated as 100% in glomerular class I, 88.5% in class IIa, 53.3% in class IIb, 36.4% in class III and 21.2% in class IV. (b) Renal survival rates in interstitial fibrosis and tubular atrophy (IFTA) scores. (c) Renal survival rates in interstitial inflammation scores. (d) Renal survival rates in arteriolar hyalinosis scores. (e) Renal survival rates in arteriosclerosis scores. Large vessel was not obtained in 13 patients. (f) Renal survival rates in the presence or nothing of exudative lesion. Abbreviation: Median time, median time for introduction of dialysis after renal biopsy
FIGURE 3:
FIGURE 3:
Univariate and multivariate Cox proportional hazard models by pathological variables at renal end point. Model 1: adjusted for age, gender, estimated glomerular filtration rate, type of diabetes, urinary protein excretion, systolic blood pressure, body mass index and HbA1c at the time of renal biopsy. Model 2: adjusted for the above plus diabetic retinopathy and red blood cells in urinary sediment at the time of renal biopsy. HR: hazard ratio, 95% CI: 95% confidence interval. G-class, glomerular class; IFTA, interstitial fibrosis and tubular atrophy scores; interinfra, interstitial inflammation scores; hyalinosis, arteriolar hyalinosis scores; A-sclerosis, arteriosclerosis scores; exudative, presence of exudative lesions.

Similar articles

Cited by

References

    1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
    1. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–2140. - PubMed
    1. Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074–1079. - PubMed
    1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341:1127–1133. - PubMed
    1. Wada T, Shimizu M, Toyama T, et al. Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol. 2012;16:96–101. - PubMed

Publication types